Evidence map›Paper›PMID 33199705›Full record

ArticleNature communications2020

Transient commensal clonal interactions can drive tumor metastasis.

Suha Naffar-Abu Amara, Hendrik J Kuiken, Laura M Selfors, Timothy Butler, Marco L Leung, Cheuk T Leung, Elaine P Kuhn, Teodora Kolarova, Carina Hage, Kripa Ganesh and 13 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2023
    Review
  14. Omics Technologies Improving Breast Cancer Research and Diagnostics.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 3 countries.

Suha Naffar-Abu AmaraDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Hendrik J KuikenDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Laura M SelforsDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-1317-7353
Timothy ButlerDepartment of Molecular and Medical Genetics, Oregon Health & Science University Portland, Portland, OR, 97239-3098, USA.
Marco L LeungDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Cheuk T LeungDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-5838-5535
Elaine P KuhnDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Teodora KolarovaDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Carina HageDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0002-5352-0742
Kripa GaneshDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Richard PanayiotouDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA.
Rosemary FosterVincent Center for Reproductive Biology and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Bo R RuedaVincent Center for Reproductive Biology and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0001-9489-8699
Athena AktipisArizona Cancer Evolution Center and Department of Psychology, Arizona State University, Tempe, AZ, 85281, USA.
Paul SpellmanDepartment of Molecular and Medical Genetics, Oregon Health & Science University Portland, Portland, OR, 97239-3098, USA.
Tan A InceDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Joanne XiuCaris Life Sciences, Phoenix, AZ, 85040, USA.
Matthew OberleyCaris Life Sciences, Phoenix, AZ, 85040, USA.ORCID 0000-0001-6419-2513
Zoran GatalicaCaris Life Sciences, Phoenix, AZ, 85040, USA.
Nicholas NavinDepartment of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Gordon B MillsDepartment of Cell, Developmental and Cancer Biology, Oregon Health and Science University Knight Cancer Institute, Portland, OR, 97239-3098, USA.ORCID 0000-0002-0144-9614
Rodrick T BronsonRodent Histopathology Core, Harvard Medical School, Boston, MA, 02115, USA.
Joan S BruggeDepartment of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA. joan_brugge@hms.harvard.edu.ORCID 0000-0002-2547-4814
Harvard University · USCaris Life Sciences (United States) · USOregon Health & Science University · USArizona State University · USChildren's Hospital of Philadelphia · USDartmouth–Hitchcock Medical Center · USNewYork–Presbyterian Brooklyn Methodist Hospital · USRoche (Switzerland) · CHThe University of Texas MD Anderson Cancer Center · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007133 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI PERNA, NICOLE T · 1985 to 2023
$16.5M
Super-Resolution ImagingP30NS072030 · NINDS · HARVARD MEDICAL SCHOOL · PI REGEHR, WADE G · 2011 to 2020
$5.8M
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor CellsR01CA181543 · NCI · HARVARD MEDICAL SCHOOL · PI BRUGGE, JOAN SIEFERT · 2014 to 2018
$2.0M
Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human CancersR33CA214310 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI INCE, TAN A. · 2018 to 2020
$1.3M
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
NCI NIH HHS R01 CA181543NCI NIH HHS R33 CA214310NCI NIH HHS R50 CA221675NIGMS NIH HHS T32 GM007133NINDS NIH HHS P30 NS072030
6 · The paper itself

Abstract

The extent and importance of functional heterogeneity and crosstalk between tumor cells is poorly understood. Here, we describe the generation of clonal populations from a patient-derived ovarian clear cell carcinoma model which forms malignant ascites and solid peritoneal tumors upon intraperitoneal transplantation in mice. The clonal populations are engineered with secreted Gaussia luciferase to monitor tumor growth dynamics and tagged with a unique DNA barcode to track their fate in multiclonal mixtures during tumor progression. Only one clone, CL31, grows robustly, generating exclusively malignant ascites. However, multiclonal mixtures form large solid peritoneal metastases, populated almost entirely by CL31, suggesting that transient cooperative interclonal interactions are sufficient to promote metastasis of CL31. CL31 uniquely harbors ERBB2 amplification, and its acquired metastatic activity in clonal mixtures is dependent on transient exposure to amphiregulin, which is exclusively secreted by non-tumorigenic clones. Amphiregulin enhances CL31 mesothelial clearance, a prerequisite for metastasis. These findings demonstrate that transient, ostensibly innocuous tumor subpopulations can promote metastases via "hit-and-run" commensal interactions.

Indexed as

Cell CommunicationAmphiregulinAnimalsAscitesCarcinogenesisCarcinoma, Renal CellCell Line, TumorCell ProliferationCell SeparationClone CellsCohort StudiesDNA Copy Number VariationsEpitheliumErb-b2 Receptor Tyrosine KinasesFemaleGene AmplificationAmphiregulinERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesLigands

Identifiers

PMID33199705
PMCPMC7669858
OpenAlexW3102437285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.